News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
831,778 Results
Type
Article (85621)
Company Profile (744)
Press Release (745413)
Section
Business (232262)
Career Advice (4106)
Deals (39645)
Drug Delivery (116)
Drug Development (90659)
Employer Resources (194)
FDA (17978)
Job Trends (17274)
News (395596)
Policy (39621)
Tag
Academia (2975)
Alliances (56462)
Alzheimer's disease (1337)
Approvals (17885)
Artificial intelligence (158)
Bankruptcy (394)
Best Places to Work (12525)
Biotechnology (509)
Breast cancer (131)
Cancer (1181)
Cardiovascular disease (109)
Career advice (3513)
Cell therapy (271)
Clinical research (71551)
Collaboration (420)
Compensation (207)
COVID-19 (2803)
C-suite (106)
Data (1159)
Diabetes (168)
Diagnostics (6683)
Earnings (94756)
Employer resources (167)
Events (126821)
Executive appointments (328)
FDA (18548)
Funding (381)
Gene therapy (204)
GLP-1 (697)
Government (5048)
Healthcare (20719)
Infectious disease (2897)
Inflammatory bowel disease (121)
Interviews (807)
IPO (17598)
Job creations (5179)
Job search strategy (2855)
Layoffs (489)
Legal (10044)
Lung cancer (190)
Manufacturing (202)
Medical device (14414)
Medtech (14419)
Mergers & acquisitions (22100)
Metabolic disorders (473)
Neuroscience (1644)
NextGen Class of 2024 (7657)
Non-profit (5065)
Northern California (1522)
Obesity (271)
Opinion (244)
Patents (112)
People (64190)
Pharmaceutical (148)
Phase I (22020)
Phase II (31074)
Phase III (23423)
Pipeline (470)
Postmarket research (3540)
Preclinical (9960)
Radiopharmaceuticals (259)
Rare diseases (246)
Real estate (7373)
Regulatory (25967)
Research institute (2642)
Resumes & cover letters (648)
Southern California (1347)
Startups (4276)
United States (14667)
Vaccines (653)
Weight loss (221)
Date
Today (92)
Last 7 days (742)
Last 30 days (4015)
Last 365 days (38593)
2024 (35446)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (228)
Asia (49350)
Australia (8697)
California (3545)
Canada (1315)
China (267)
Colorado (159)
Connecticut (173)
Europe (113033)
Florida (476)
Georgia (127)
Illinois (418)
Indiana (216)
Kansas (103)
Maryland (631)
Massachusetts (2864)
Michigan (179)
Minnesota (299)
New Jersey (1010)
New York (1007)
North Carolina (844)
Northern California (1522)
Ohio (149)
Pennsylvania (873)
South America (1647)
Southern California (1347)
Texas (512)
Washington State (403)
There are 831,778 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Editorial
Trump’s ‘Team of Self Promoters’ Will Make for Great Reality TV but an Uncertain Biopharma Environment
RFK Jr. as HHS head is perhaps President-elect Donald Trump’s most controversial Cabinet pick now that Matt Gaetz has withdrawn as nominee for Attorney General. With Dr. Oz tapped to lead CMS and maybe Marty Makary at the FDA, it’s going to be quite the show.
November 22, 2024
·
6 min read
·
Jef Akst
Layoff Tracker
Sonata Therapeutics Laying off 20 Employees, Changing Leadership
Follow along as
BioSpace
keeps you up-to-date on the latest pharma and biotech layoffs.
November 22, 2024
·
187 min read
·
BioSpace Editorial Staff
Postmarket research
Merck’s Former Asthma Blockbuster Singulair Could be Linked to Mental Health Problems: Reuters
A
Reuters
report on Friday revealed that FDA researchers have found additional molecular evidence tying blockbuster asthma therapy montelukast to adverse neuropsychiatric effects.
November 22, 2024
·
2 min read
·
Tristan Manalac
Press Releases
OverT Bio Receives $120K G-Rex® Grant to Propel Solid Tumor Cell Therapy Advancements
November 22, 2024
·
3 min read
Press Releases
Scilex Holding Company Announces Receipt of Notice from Nasdaq
November 22, 2024
·
6 min read
Press Releases
Akeso’s Penpulimab Combination Therapy for First-line Treatment of Hepatocellular Carcinoma Accepted by NMPA
November 22, 2024
·
4 min read
Press Releases
Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
November 22, 2024
·
1 min read
Press Releases
Eyenovia Provides Update on Restructuring Efforts
November 22, 2024
·
4 min read
Press Releases
NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path Forward to Regain Compliance
November 22, 2024
·
5 min read
Press Releases
Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA
November 22, 2024
·
5 min read
1 of 83,178
Next
